Incidence of hepatitis A in the United States in the era of vaccination.
about
Dissecting the indirect effects caused by vaccines into the basic elementsArsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003-2012Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based studyThe costs of hepatitis A infections in South Korea.Diagnosis of hepatitis a virus infection: a molecular approach.Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy korean adults.Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases.Hepatitis A surveillance and vaccine use in China from 1990 through 2007Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolatesThe effect of policy changes on hepatitis A vaccine uptake in Arizona children, 1995-2008.Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey.Changing trends in viral hepatitis-associated hospitalizations in the American Indian/Alaska Native population, 1995-2007Hepatitis A virus genotype distribution during a decade of universal vaccination of preadolescentsDeterminants of anti-hepatitis A antibody seroprevalence in 2- to 19-year-olds in the USA using NHANES 2007-2008Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination programChange in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003-2006 and 2007-2010.Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review.Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic reviewPrevention of hepatitis A by Havrix: a review.Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomesShould all children be immunised against hepatitis A?Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002--a review.Vaccination against hepatitis A in children: A review of the evidence.Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®Shifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination.Hepatitis A vaccination in developing countries: Is Syria next?Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, ChinaMonitoring the impact of vaccines postlicensure: new challenges, new opportunities.Epaxal: a virosomal vaccine to prevent hepatitis A infection.Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program.Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.Hepatitis A Vaccine Response in Human Immunodeficiency Virus-infected Patients: The Interchangeability of Single Dose versus Double: A Prospective Look.The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012).Viral hepatitis in the elderly.Hepatitis A virus evolution and the potential emergence of new variants escaping the presently available vaccines.Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.Diagnostic markers for hepatitis virus infection.
P2860
Q26799527-43F219D4-E944-4A6C-8839-0779CF6FDA51Q28393717-E00CCE31-455B-4413-ABED-027CC07B1A66Q28657724-099413B9-153A-40C2-A9C1-3930FD2840C3Q33265523-42E93B1B-FCE0-4445-AE90-303CF1337977Q33289925-62B3B5CB-EA4F-4823-A7DB-C04F2AFF2C47Q34132167-A4D154B1-E689-4B6D-BC7C-73100F60C8CEQ34334021-6F8039C3-340F-4427-889B-62D7D85B4734Q34725927-20586422-BCE3-4B84-A293-33F4F74101CAQ34767141-E1A4765A-7BE1-408D-BB3F-62C89679541FQ34989500-0BE49C39-7EB2-489B-9FFD-19038A5FB46FQ34999311-677C7BC2-E3B6-4918-8DEB-D11489A63942Q35040478-461085EE-EBE0-4016-8B26-3E2DE89CFE06Q35045744-70608EAE-5BFA-4269-89E7-BD6B9B48314DQ35258162-367C0856-05A6-4ED2-950C-B768017F30D4Q35585415-2BCD98E8-865E-47E1-A606-B0EF1C5DBA5CQ35701038-EA76A7D7-A805-4118-B363-8DCDD8AA9C44Q35887376-9249F475-F6F4-4B01-907C-A3A08C726AF5Q35890615-5511CECD-2905-4EE8-9E7C-54A9D82C13D0Q36075046-3D20E7DC-5E9A-4CB5-A41A-4087348F1CB1Q36175752-D134ABAD-ECD9-4E91-A12A-41BA533FC950Q36238689-EB22458A-81A0-49D8-B52B-E89F7DF6B689Q36421177-44608DF6-0A6A-4580-9F19-3EBE497E3ABBQ36431979-A2EFFB79-65CE-4CF4-AC9B-87B7D5123268Q36531888-E0C6B604-9488-4FFF-9599-E488E1CE3366Q36663673-ABC01876-006C-42BD-AF18-CE465E0D7A12Q36849799-42C0C598-C18F-420C-BEDE-F87135FA3363Q36934533-74484E2A-78B4-4A4F-95E8-2BE88B6E43B3Q36970157-BA1EE309-4997-472F-B383-4268504A2408Q36977765-B202C506-4D18-40E3-9983-8618CC11CB0FQ37150315-4B3B8ECB-EB25-46BD-AB6F-EFA4BF560B62Q37290088-5504FAF6-3900-4CC1-8009-AF4CED2360AEQ37355475-AE2307EF-A0DB-4740-ABA2-C2A2A583E341Q37404930-9F83AED9-8D6A-4B41-A434-99FC643CCEA3Q37449617-B6811DC2-AA55-4E02-BC23-54D5AAB48419Q37521932-977E561F-767D-410E-88C1-82055419D74FQ37673146-BFABBC9F-AB68-4DC3-BC24-7FF6A6936404Q37980037-162B472E-C4D4-4E49-BD02-CA4D214B6BD6Q37990939-EA2C55D7-5601-4A08-A7F5-44697D50C2C0Q38017820-8A437547-99F7-460A-9CD7-3BC467FBE2D2Q38089735-D44FE168-7118-4046-AEED-4FDF86F09F4C
P2860
Incidence of hepatitis A in the United States in the era of vaccination.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Incidence of hepatitis A in the United States in the era of vaccination.
@en
Incidence of hepatitis A in the United States in the era of vaccination.
@nl
type
label
Incidence of hepatitis A in the United States in the era of vaccination.
@en
Incidence of hepatitis A in the United States in the era of vaccination.
@nl
prefLabel
Incidence of hepatitis A in the United States in the era of vaccination.
@en
Incidence of hepatitis A in the United States in the era of vaccination.
@nl
P2093
P356
P1476
Incidence of hepatitis A in the United States in the era of vaccination.
@en
P2093
Annemarie Wasley
Beth P Bell
Taraz Samandari
P304
P356
10.1001/JAMA.294.2.194
P407
P577
2005-07-01T00:00:00Z